| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 88.08B | 84.31B | 70.98B | 87.00B | 65.54B | 51.33B |
| Gross Profit | 16.98B | 16.47B | 10.75B | 9.14B | 14.13B | 12.35B |
| EBITDA | 20.59B | 19.98B | 13.96B | 22.29B | 13.87B | 9.67B |
| Net Income | 9.81B | 9.34B | 4.53B | 12.10B | 6.78B | 4.00B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 131.48B | 118.30B | 114.21B | 87.44B | 71.61B |
| Cash, Cash Equivalents and Short-Term Investments | 6.27B | 6.27B | 6.28B | 11.08B | 11.58B | 7.16B |
| Total Debt | 0.00 | 41.52B | 41.49B | 36.99B | 26.56B | 25.93B |
| Total Liabilities | -62.54B | 68.94B | 63.84B | 62.28B | 47.42B | 43.61B |
| Stockholders Equity | 62.54B | 62.37B | 54.08B | 50.67B | 38.84B | 27.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.44B | -1.53B | -7.16B | 2.21B | 10.11B |
| Operating Cash Flow | 0.00 | 18.80B | 7.32B | 4.93B | 12.11B | 12.47B |
| Investing Cash Flow | 0.00 | -10.62B | -3.75B | -9.79B | -14.30B | -6.34B |
| Financing Cash Flow | 0.00 | -6.89B | -4.10B | 6.04B | 2.21B | -6.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹153.27B | 28.71 | ― | 0.80% | 21.68% | 45.18% | |
70 Outperform | ₹66.21B | 12.10 | ― | 3.68% | -7.53% | 42.74% | |
65 Neutral | ₹48.07B | -46.40 | ― | 3.11% | 10.35% | ― | |
65 Neutral | ₹62.76B | 23.54 | ― | 0.47% | 5.61% | 33.63% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | ₹183.40B | -52.43 | ― | 1.42% | -1.99% | ― | |
52 Neutral | ₹207.40B | 59.14 | ― | 0.44% | -7.50% | -37.67% |